Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
SUO 2025
SABCS 2025
ASH 2025
JADPRO Live 2025
ESMO Congress 2025
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
SUO 2025
«
1
»
Advertisement
Advertisement
Dec
17
Today In Oncology
Community Oncology Report Showcases Barriers to Therapy Access, Staffing, and Clinical Trial Participation
FDA Approves CAR T-Cell Therapy for Relapsed/Refractory Marginal Zone Lymphoma
Addition of Eflornithine to Lomustine in Patients With Recurrent Grade 3 Astrocytoma
Preoperative PAXG vs mFOLFIRINOX in Pancreatic Ductal Adenocarcinoma
Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced NSCLC
View More
Advertisement
